ModernaMRNA

NASDAQ · USA · Segment 3 of 8 in the Medicine, pharma & life science value chain: Biotech & innovation

American biotech company based on mRNA technology — known for the covid vaccine, with a pipeline in vaccines and oncology.

Biotech & innovation: Innovation-driven biotech companies focused on novel treatment modalities.

Key metrics

Market cap

$30.3B

Price

$68.56

Today

−10.4%

Return YTD

+159.6%

Return 1Y

+133.5%

P/E

—

P/S

13.6

P/B

4.1

Data as of 2026-07-10 · updates daily after U.S. close

Theme exposure

BiotechmRNAVaccines

In the value chain

Products & services

mRNA vaccines
Oncology pipeline
Rare diseases

Competitors

Pfizer/BioNTech
Novavax

Risks

Declining covid revenue
Pipeline still maturing

Same segment: Biotech & innovation

AmgenAMGN Gilead SciencesGILD Vertex PharmaceuticalsVRTX RegeneronREGN Alnylam PharmaceuticalsALNY BiogenBIIB IncyteINCY United TherapeuticsUTHR

See where Moderna sits in the full Medicine, pharma & life science map — every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →